Pharmacology & Prescribing
11 articlesEvidence-based medication safety guidance for use during pregnancy and lactation.
What Happens After You Refer a Patient to Phoenix Health
A step-by-step description of the patient experience after a clinical referral to Phoenix Health: intake process, therapist matching, first appointment, ongoing care, and collaborative care communication.
Read article →When to Start vs. Discontinue Psychiatric Medication in Pregnancy
Psychiatric medication decisions in pregnancy are clinical decisions, not defaults. A framework for prescribers evaluating when to start, continue, taper, or discontinue psychiatric medications across the perinatal period.
Read article →
Co-Prescribing for PMAD Patients in Therapy: A Framework
PMAD patients frequently receive medication from one provider and therapy from another. A clinical framework for prescribers managing the medication component of combined treatment, including communication with therapists, timing considerations, and when to escalate.
Read article →
Benzodiazepine Use in Perinatal Anxiety: Safety, Risks, and Alternatives
Benzodiazepines are commonly requested by pregnant and postpartum patients with anxiety. A clinical prescribing reference covering teratogenicity data, use in pregnancy and breastfeeding, appropriate clinical positioning, and evidence-based alternatives.
Read article →
Perinatal Psychosis: Recognition, Triage, Hospitalization Criteria, and Medication
Postpartum psychosis is a psychiatric emergency with a rapid onset and serious consequences if missed or mismanaged. A clinical reference for recognition, immediate triage, hospitalization decision-making, and acute pharmacological management.
Read article →
Choosing a Perinatal Mental Health Referral Partner: What OB and Midwifery Practices Should Look For
What to look for in a perinatal mental health referral partner: PMH-C certification, response time, telehealth, insurance coverage, and collaborative care.
Read article →
When Postpartum Patients Need Psychiatric Consultation
Signs that postpartum depression or anxiety requires psychiatric consultation, what OBs can initiate versus refer, and how to communicate the handoff.
Read article →
Collaborative Care Models for PMADs: Evidence and Implementation
How collaborative care between OBGYNs, pediatricians, therapists, and prescribers improves PMAD outcomes. Evidence base, implementation frameworks, and practical coordination protocols.
Read article →
Perinatal Psychopharmacology for Prescribers: A Complete Clinical Reference
A comprehensive prescriber reference covering antidepressants in pregnancy and breastfeeding, brexanolone and zuranolone, benzodiazepines, antipsychotics, medication decision-making frameworks, and co-prescribing with therapy for the full PMAD spectrum.
Read article →
Antidepressants During Pregnancy: Balancing Fetal Risk and Maternal Benefit
The decision to prescribe, continue, or taper antidepressants in pregnancy involves weighing documented fetal exposures against the well-established risks of untreated perinatal depression. A clinical reference for prescribers navigating this decision with pregnant patients.
Read article →
Brexanolone and Zuranolone: What Prescribers Need to Know
Two FDA-approved neuroactive steroid agents for postpartum depression represent a new mechanism class. A clinical prescribing reference covering indications, clinical trial data, patient selection, breastfeeding guidance, and practical access considerations.
Read article →Ready to refer a patient?
Phoenix Health connects your patients with PMH-C certified therapists, covered by insurance.